Management Updates for Women with a BRCA1 or BRCA2 Mutation

Author： Nusbaum Rachel   Isaacs Claudine  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.11, Iss.3, 2007-01, pp. : 133-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Haffty B.G.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-641

Elsevier

Access to resources Recommend Favorite

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Vaidya J.S.   Baum M.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-640

Elsevier

Access to resources Recommend Favorite

Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1136-1146

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRCA1 and BRCA2 Molecular Testing in Women with Different Risk of Hereditary Breast Cancer: ost/Effectiveness and Psychological Implications

By  

Current Women's Health Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 12-16

Bentham Science Publishers

Access to resources Recommend Favorite

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 7, 2015-10 ,pp. : 1729-1738

John Wiley & Sons Inc

Access to resources Recommend Favorite